
High-throughput epigenomic profiling using precision bisulfite conversion and targeted sequencing to identify DNA-protein interactions.
Epigenomics is the study of alterations in an organism’s gene expression that do not involve changes to the underlying DNA sequence. Central to this is DNA methylation, a key mechanism of transcriptional regulation.
Our facility pairs high-throughput DNA sequencing with precision sodium bisulfite conversion, enabling the analysis of both methylated and unmethylated cytosines at single-base resolution.
Reliable conversion for base-level resolution.
Comprehensive mapping of every CpG site.
Expert ChIP-Seq for binding site discovery.
Highly accurate measurement of 5mC/5hmC.
Get comprehensive, single-base resolution of DNA methylation patterns across the entire genome.
Precision-targeted approach to verify specific regions of interest found in genome-wide analyses.
Identifying genome-wide DNA binding sites for transcription factors and chromatin-associated proteins.
Differential detection and quantification of 5-methylcytosine and 5-hydroxymethylcytosine.
Proven precision conversion of unmethylated cytosines to uracil while shielding methylcytosines.
Quantitative measurement of DNA methylation levels at specific genomic loci or promoter regions.
Isolating intact genomic DNA
Cytosine-to-uracil transformation
NGS-ready template generation
High-throughput data capture
CpG mapping & methylation scoring
"Our 5mC/5hmC sequencing service utilizes established, high-accuracy systems to differentially detect methylation states, providing a deeper layer of epigenomic insight beyond standard bisulfite conversion."
Mapping the regulatory landscape in health and disease.
Our facility maintains ISO-certified protocols for bisulfite conversion, ensuring over 99% conversion efficiency while preserving template integrity.
Standardized profiling for research and clinical studies
Bisulfite Validation
Whole Genome Mapping
ChIP & Methylation
Download our technical brochure to explore bisulfite conversion workflows, NGS platforms, and targeted methylation panels.